Methods
From June to October 2020, based on the oncohematological department of
the National Research Oncology Center LLP, 19 patients were treated, of
which: men - 11, women - 8. The average age of 43 years (+-16). Of
these, patients with multiple myeloma-32%; acute myeloid leukemia -
26%; acute promyelocytic leukemia - 11%; acute lymphoblastic leukemia
- 26%; chronic lymphocytic leukemia - 5%. Treatment was carried out
following the protocols for the diagnosis and treatment of hemoblastosis
and concomitant COVID-19 infection (11).